With the recent NeuroInsights conference and other talks I have given there have been several articles that have appeared in magazines, journals and newspapers. Here are links to some of them:
Science Business: Neurotechnology - The Next Frontier
With global revenues of $110 billion last year, and an aging population, the nascent "neurotechnology" market appears poised for huge growth. June 1, 2006. (registration req'd)
M&C News: Human Enhancement: Problem or Solution?
Since the advent of simple tools, humans have been expanding their capacities. Cognitive enhancement dates back to the written word, a primitive process for downloading information from our minds to the hard drive of parchment. June 2, 2006.
Nature Biotechnology: Monoclonals Expand into Neural Disorders
In April, Pfizer bought a Genentech spinoff, Rinat Neuroscience, for "close to $500 million dollars," according to one source. What drew Pfizer's interest to Rinat was its pipeline, in particular, two of its most advanced drugs. June 2, 2006. (subscription req'd)
Cox News Service: Ethical concerns line biomedicine's path
Much of the discussion centered around the rapidly growing field of "neurotechnology" and its ability to enhance cognition, or make people smarter.
Expresso (In Portuguese) - Chegou a indústria do cérebro Reposted here and here without subscription. A investigação em neurociências passou do laboratório para o mercado. Zack Lynch vê nos 1500 milhões de doentesnas áreas das neurociências um «efeito multiplicador» no mercadoda saúde. O QUE há uns anos era investigação futurista sobre os mistérios do nosso cérebro passou para o mercado e é mais uma janela de oportunidade para a biotecnologia.